IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.466
NA - Nord America 1.412
EU - Europa 655
SA - Sud America 445
AF - Africa 42
OC - Oceania 4
Totale 4.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.351
SG - Singapore 606
BR - Brasile 366
CN - Cina 310
VN - Vietnam 153
IT - Italia 147
HK - Hong Kong 144
DE - Germania 134
BD - Bangladesh 74
RU - Federazione Russa 68
GB - Regno Unito 64
FR - Francia 60
TR - Turchia 55
IN - India 33
CZ - Repubblica Ceca 32
CA - Canada 31
AR - Argentina 28
AT - Austria 26
UA - Ucraina 26
FI - Finlandia 23
MX - Messico 18
NL - Olanda 18
EC - Ecuador 17
JP - Giappone 16
ZA - Sudafrica 14
ID - Indonesia 13
PL - Polonia 13
SE - Svezia 12
IQ - Iraq 9
PY - Paraguay 8
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 7
CL - Cile 6
CO - Colombia 6
KE - Kenya 6
UZ - Uzbekistan 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
TW - Taiwan 4
AZ - Azerbaigian 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
EG - Egitto 2
ET - Etiopia 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
Totale 4.024
Salva come PNG Salva come JPEG
Città #
Singapore 292
San Jose 163
Ashburn 159
Hong Kong 144
The Dalles 119
Beijing 64
Los Angeles 59
Ho Chi Minh City 53
New York 52
Lauterbourg 49
Dallas 48
Istanbul 47
Munich 40
Hanoi 38
Boardman 35
Fairfield 32
Nuremberg 32
Santa Clara 32
Des Moines 31
Moscow 28
São Paulo 28
Buffalo 27
Council Bluffs 26
Romola 24
Houston 23
Chicago 22
San Francisco 21
Woodbridge 21
Redondo Beach 19
Olomouc 17
Orem 16
Shanghai 16
Turku 16
Brno 15
Denver 15
Milan 15
Mumbai 14
Rio de Janeiro 14
Seattle 14
Tokyo 14
London 13
Manchester 13
Vienna 13
Frankfurt am Main 12
Montreal 12
Stockholm 12
Atlanta 11
Warsaw 11
Boston 10
Brooklyn 10
Charlotte 10
Jacksonville 10
Wilmington 10
Curitiba 9
Rome 9
Belo Horizonte 8
Cambridge 8
Mexico City 8
Phoenix 8
Poplar 8
Ribeirão Preto 8
Toronto 8
Amsterdam 7
Chandler 7
Düsseldorf 7
Helsinki 7
Porto Alegre 7
Chennai 6
Hải Dương 6
Nairobi 6
Naples 6
Tashkent 6
Amman 5
Brussels 5
Buenos Aires 5
Cape Town 5
Dearborn 5
Goiânia 5
Guayaquil 5
Jinan 5
Johannesburg 5
Kunming 5
New Delhi 5
Ottawa 5
Padova 5
Philadelphia 5
Quito 5
São José dos Campos 5
Biên Hòa 4
Brasília 4
Cotia 4
Da Nang 4
Dhaka 4
Florence 4
Imperatriz 4
Ipatinga 4
Nanjing 4
Nova Iguaçu 4
Petrolina 4
Princeton 4
Totale 2.308
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 222
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 200
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 96
Applying the ATN scheme in a memory clinic population: The ABIDE project 94
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 93
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 93
Clinical utility of FDG-PET for the clinical diagnosis in MCI 92
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 91
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 91
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 90
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 90
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 90
Brain atrophy in Alzheimer's Disease and aging 88
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 87
AMYPAD Diagnostic and Patient Management Study: Rationale and design 86
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 85
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 85
Medial temporal lobe atrophy and posterior atrophy scales normative values 82
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 82
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 82
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 82
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 80
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 77
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 76
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 76
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 76
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 75
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 74
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 74
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 73
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 72
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 71
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 69
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 69
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 68
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 66
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 66
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 66
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 64
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 63
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 63
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 63
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 62
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 55
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 55
Multitracer model for staging cortical amyloid deposition using PET imaging 50
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 46
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 45
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 45
Feasibility of a standard cognitive assessment in European academic memory clinics 44
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 37
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology 37
The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection 22
Totale 4.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202222 1 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024214 3 2 7 0 0 11 2 1 5 55 16 112
2024/20251.152 31 1 57 148 76 79 137 17 189 84 195 138
2025/20262.470 221 367 201 362 234 149 326 68 147 190 141 64
Totale 4.080